Chemoinformaics analysis of 6-(2,2-Dimethylcyclopropyl)furo[3,2-g]chromen-7-one
| Molecular Weight | 254.285 | nRot | 1 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 19 |
| Exact Molecular Weight | 254.094 | nRing | 4 |
| Solubility: LogS | -6.777 | nHRing | 2 |
| Solubility: LogP | 4.442 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 15 |
| nHA | 3 | APOL | 38.4611 |
| nHD | 0 | BPOL | 18.3849 |
| QED | 0.615 |
| Synth | 3.296 |
| Natural Product Likeliness | 1.247 |
| NR-PPAR-gamma | 0.099 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.971 |
| Pgp-sub | 0.919 |
| HIA | 0.003 |
| CACO-2 | -4.76 |
| MDCK | 0.0000211 |
| BBB | 0.018 |
| PPB | 0.976731 |
| VDSS | 0.801 |
| FU | 0.0481178 |
| CYP1A2-inh | 0.948 |
| CYP1A2-sub | 0.74 |
| CYP2c19-inh | 0.864 |
| CYP2c19-sub | 0.292 |
| CYP2c9-inh | 0.753 |
| CYP2c9-sub | 0.899 |
| CYP2d6-inh | 0.566 |
| CYP2d6-sub | 0.8 |
| CYP3a4-inh | 0.155 |
| CYP3a4-sub | 0.229 |
| CL | 2.878 |
| T12 | 0.139 |
| hERG | 0.028 |
| Ames | 0.01 |
| ROA | 0.873 |
| SkinSen | 0.118 |
| Carcinogencity | 0.281 |
| EI | 0.276 |
| Respiratory | 0.87 |
| NR-Aromatase | 0.524 |
| Antiviral | Yes |
| Prediction | 0.733236 |